Lincocin

In some countries, this medicine may only be approved for veterinary use.

In the US, Lincocin (lincomycin systemic) is a member of the drug class lincomycin derivatives and is used to treat Bacterial Infection and Conjunctivitis - Bacterial.

US matches:

• Lincocin

Ingredient matches for Lincocin

Lincomycin

Lincomycin is reported as an ingredient of Lincocin in the following countries:

• Turkey

Lincomycin hydrochloride monohydrate (a derivative of Lincomycin) is reported as an ingredient of Lincocin in the following countries:

• Australia


• Austria


• Bahrain


• Belgium


• Bosnia & Herzegowina


• Canada


• Chile


• Colombia


• Costa Rica


• Ecuador


• El Salvador


• Finland


• Georgia


• Ghana


• Greece


• Guatemala


• Honduras


• Hong Kong


• Indonesia


• Ireland


• Italy


• Japan


• Kenya


• Latvia


• Liberia


• Lithuania


• Luxembourg


• Mexico


• Netherlands


• Nicaragua


• Norway


• Oman


• Panama


• Peru


• Philippines


• Poland


• Romania


• Sierra Leone


• Singapore


• South Africa


• Spain


• Tanzania


• Thailand


• Uganda


• United Kingdom


• United States


• Venezuela


• Vietnam


• Zimbabwe

International Drug Name Search

Epirubicine Hospira

Epirubicine Hospira may be available in the countries listed below.

Ingredient matches for Epirubicine Hospira

Epirubicin

Epirubicin hydrochloride (a derivative of Epirubicin) is reported as an ingredient of Epirubicine Hospira in the following countries:

• France

International Drug Name Search

PrandiMet

In the US, PrandiMet (metformin/repaglinide systemic) is a member of the drug class antidiabetic combinations and is used to treat Diabetes, Type 2.

US matches:

• PrandiMet

Ingredient matches for PrandiMet

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of PrandiMet in the following countries:

• United States

Pioglitazone

Pioglitazone hydrochloride (a derivative of Pioglitazone) is reported as an ingredient of PrandiMet in the following countries:

• United States

International Drug Name Search

Alprazolam ratiopharm

Alprazolam-ratiopharm may be available in the countries listed below.

Ingredient matches for Alprazolam-ratiopharm

Alprazolam

Alprazolam is reported as an ingredient of Alprazolam-ratiopharm in the following countries:

• Austria


• France


• Germany


• Italy


• Netherlands


• Portugal


• Spain

International Drug Name Search

Norbactin

Norbactin may be available in the countries listed below.

Ingredient matches for Norbactin

Norfloxacin

Norfloxacin is reported as an ingredient of Norbactin in the following countries:

• India


• Latvia


• Lithuania


• Oman


• Peru


• Singapore


• Sri Lanka

International Drug Name Search

Enablex

Enablex is a brand name of darifenacin, approved by the FDA in the following formulation(s):

ENABLEX (darifenacin hydrobromide - tablet, extended release; oral)

• 
  Manufacturer: WARNER CHILCOTT LLC
  
  Approval date: December 22, 2004
  
  Strength(s): EQ 15MG BASE ^[RLD], EQ 7.5MG BASE
  

Has a generic version of Enablex been approved?

No. There is currently no therapeutically equivalent version of Enablex available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Enablex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pyrrolidine derivatives
  Patent 5,096,890
  Issued: March 17, 1992
  Inventor(s): Cross; Peter E. & MacKenzie; Alexander R.
  Assignee(s): Pfizer Inc.
  Compounds of the formula ##STR1## wherein R, Y and R.sup.1 are as defined in the specification. These compounds are muscarinic receptor antagonists which are selective for smooth muscle muscarinic sites over cardiac muscarinic sites, and are useful in the treatment of diseases associated with altered motility on tone of smooth muscle, including irritable bowel syndrome, diverticular disease, urinary incontinence, oesophageal achalasia and chronic obstructive airways disease.
  
  Patent expiration dates:
  
  
  • March 13, 2015
    
    ✓ 
    Patent use: TREATING A DISEASE OF ALTERED MOTILITY OR TONE OF SMOOTH MUSCLE BY ADMINISTERING A MUSCARINIC RECEPTOR ANTAGONIZING AMOUNT OF DARIFENACIN
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Pharmaceutical formulations containing darifenacin
  Patent 6,106,864
  Issued: August 22, 2000
  Inventor(s): Dolan; Thomas Francis & Humphrey; Michael John & Nichols; Donald John
  Assignee(s): Pfizer Inc.
  There is provided a pharmaceutical dosage form adapted for administration to the gastrointestinal tract of a patient, comprising darifenacin, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable adjuvant, diluent or carrier, characterized in that the dosage form is adapted to deliver at least 10% by weight of the darifenacin, or the pharmaceutically acceptable salt thereof, to the lower gastrointestinal tract of the patient. The formulation minimizes unwanted side-effects and increases the bioavailability of darifenacin.
  
  Patent expiration dates:
  
  
  • August 21, 2016
    
    ✓ 
    Patent use: TREATING URINARY INCONTINENCE BY ADMINISTERING AN EXTENDED-RELEASE FORM OF DARIFENACIN
    ✓ 
    Drug product
  
  

See also...

• Enablex Consumer Information (Drugs.com)
• Enablex Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Enablex Consumer Information (Cerner Multum)
• Enablex Advanced Consumer Information (Micromedex)
• Enablex AHFS DI Monographs (ASHP)
• Darifenacin Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Darifenacin Consumer Information (Cerner Multum)
• Darifenacin Advanced Consumer Information (Micromedex)
• Darifenacin Hydrobromide AHFS DI Monographs (ASHP)

Nicotinell Lutschtabletten

Nicotinell Lutschtabletten may be available in the countries listed below.

Ingredient matches for Nicotinell Lutschtabletten

Nicotine

Nicotine bitartrate dihydrate (a derivative of Nicotine) is reported as an ingredient of Nicotinell Lutschtabletten in the following countries:

• Switzerland

International Drug Name Search

Divina

Divina may be available in the countries listed below.

Ingredient matches for Divina

Estradiol

Estradiol is reported as an ingredient of Divina in the following countries:

• Tunisia

Estradiol 17ß-valerate (a derivative of Estradiol) is reported as an ingredient of Divina in the following countries:

• Czech Republic


• Finland


• France


• Greece


• Hungary


• Poland


• Slovakia


• Turkey

Medroxyprogesterone

Medroxyprogesterone is reported as an ingredient of Divina in the following countries:

• Hungary


• Tunisia


• Turkey

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Divina in the following countries:

• France


• Greece


• Poland


• Slovakia

International Drug Name Search

Tolbutamina

Tolbutamina may be available in the countries listed below.

Ingredient matches for Tolbutamina

Tolbutamide

Tolbutamide is reported as an ingredient of Tolbutamina in the following countries:

• Chile

International Drug Name Search